Assessment of treatment outcomes for HIV Positives transitioned from Tenofovir/Lamivudine/Efavirenz to Tenofovir/Lamivudine/Dolutegravir in a Nigerian Tertiary Hospital

Assessment of treatment outcomes for HIV Positives transitioned from Tenofovir/Lamivudine/Efavirenz to Tenofovir/Lamivudine/Dolutegravir in a Nigerian Tertiary Hospital

Objective: Dolutegravir, an integrase inhibitor replaced nevirapine or efavirenz (both NRTIs) in a fixed dose combination with Tenofovir/Lamivudine, as the preferred first-line option for the prevention and treatment of HIV infection. This study aimed to assess the treatment outcomes of the new Ten...

Full description

Bibliographic Details
Main Authors: Omobola Yetunde Ojo, AbdulMumin Ahmed, Adeyinka Adeniran, Olarenwaju Olusola Onigbogi, Modupe Olajumoke Onigbogi, Kamil Olanipekun Alausa
Format: Article
Language:English
Published: Babcock Medical Society 2023-12-01
Series:Babcock University Medical Journal
Subjects:
HIV-positive
Dolutegravir
Transitioned
Treatment outcome
Nigeria
Online Access:https://bumj.babcock.edu.ng/index.php/bumj/article/view/299

Internet

https://bumj.babcock.edu.ng/index.php/bumj/article/view/299

Similar Items